The PINK1/PRKN pathway is activated by oxidative stress established in DKD whereas treatment with the mitochondrial antioxidant, MitoQ, has been suggested to protect from DKD by increasing mitophagy levels (218). This evidence concerns the gene PRKN and diabetic kidney disease.